Latest news
China’s First Approved MSC Therapy, Ruibosheng, Hits the Market at a Fraction of Global Pricing - BioInformantBioInformant · Mon, 03 Aug 2026 07:00:00 GMTClean Meat Market: Stem Cell Derived “Clean Meat” Attracts Billionaires - BioInformantBioInformant · Mon, 03 Aug 2026 07:00:00 GMTThe Pipeline for iPSC-Derived Cell Therapeutics in 2026 - BioInformantBioInformant · Sun, 02 Aug 2026 07:00:00 GMTTop Companies Developing Cell Therapy Treatments For Diabetes in 2026 - BioInformantBioInformant · Thu, 30 Jul 2026 07:00:00 GMTKyverna Therapeutics and ElevateBio Enter into Commercial Manufacturing and Supply Agreement for Miv-cel - BioInformantBioInformant · Mon, 27 Jul 2026 22:25:13 GMT